Accept the term sheet only if the investor treats your paying niche as a market worth understanding, not disposable evidence for a different company. When capital requires you to demote real customers into a testing ground, the money may shorten your path to funding while lengthening your path to a durable product.
In 1985, Roberto Goizueta and Coca-Cola faced a decision that had already absorbed years of research. Pepsi was gaining ground in taste tests, and Coca-Cola had tested a sweeter reformulation with nearly 200,000 consumers. The research pointed toward replacing the original formula.
Then the company did it.
What Coca-Cola’s research failed to classify
Coca-Cola introduced New Coke in April 1985. The product had performed well in blind tests, but the tests had asked a narrower question than the company’s decision required.
People were choosing a sip. Coca-Cola was replacing a product they had bought, recognized and attached meaning to for decades.
Thomas Oliver documents the episode in The Real Coke, The Real Story. The backlash became clear after launch. Customers called and wrote to the company. Some sought out remaining stocks of the original drink. Seventy-nine days after introducing New Coke, Coca-Cola announced the return of the old formula as Coca-Cola Classic.
The research itself had not been useless. It had measured taste under controlled conditions. The failure came from reclassifying existing customers as participants in a product test, then treating that test as sufficient evidence for changing the relationship.
That is the shape of the decision inside this term sheet.
Your investor sees the niche as a useful place to test pricing, onboarding and the first version of the product. You see customers in Accra, Lagos, Berlin or Atlanta who already pay because the product solves a specific problem. Both descriptions can sound true. Only one of them determines what gets protected after the money arrives.
Read the market thesis behind the money
The most important sentence in a term sheet may sit outside the legal clauses. It can appear in the investor’s explanation of the opportunity:
“This segment proves the model before you move into the larger market.”
That sentence contains a product strategy. It says the people funding the company expect the current customer to become less important over time. Future hiring, pricing and roadmap decisions will be judged against the larger market they believe should replace the present one.
With 48 hours left, I would stop debating whether the valuation is generous. I would ask the investor to describe the company three years from now.
Who is paying?
Which customer problems still receive engineering time?
What evidence would persuade them that the current niche deserves continued investment?
What happens if expansion produces more meetings but weaker retention than the niche already delivers?
The answers matter because a term sheet can preserve legal control while changing practical control. A founder still holds the title, but every board discussion begins from an assumption that the first customers were temporary.
I have seen the same pressure appear in roadmap decisions. A contract, partnership or funding memo quietly decides which customer counts. The spreadsheet that revealed who really owns your roadmap is rarely complicated. It simply makes the trade visible.
Separate a beachhead from a disposable customer
A niche can be a beachhead. The word describes a starting position from which the company can expand while retaining what made the position defensible.
A testing ground is different. Its value comes from what the company learns before moving on.
That distinction should change the founder’s response.
If the investor sees expansion as serving adjacent customers with the same core problem, the capital may strengthen the product. The team can improve reliability, shorten setup and build distribution without abandoning the people who supplied the original evidence.
If the investor expects a different buyer, sales motion and product, the proposed company may already be a pivot. The term sheet is financing that pivot before it has been named.
This is where founders on limited runway can talk themselves into a false binary. Accepting the money feels like choosing survival. Declining it feels like choosing conviction. The real choice is more specific: which uncertainty should the company fund next?
A founder who has not proved renewal should probably spend the next period learning why customers stay. Capital tied to an upmarket story may instead fund senior hires, compliance work and sales cycles for demand that remains assumed. The funding memo that assumed unearned demand shows how quickly that assumption reaches the hiring plan.
Put the classification in writing
Before the 48 hours end, write one page with two columns.
In the first, describe the company your paying customers are currently funding: their problem, why they pay, what remains unproven and which next decision would reduce that uncertainty.
In the second, describe the company implied by the investor’s language: the future buyer, the required product changes, the sales cycle and the evidence supporting that move.
Send the investor the gap. Ask them to respond to it directly.
Coca-Cola could restore its original formula after 79 days. A startup that hires for the wrong buyer, changes its roadmap and teaches its board to dismiss current revenue may need far longer to reverse course.
The term sheet deserves a signature only after both sides agree on who the customer is. If the investor still calls today’s payer a testing ground, treat that sentence as a condition of the capital, because it will shape decisions long after the money reaches the bank.
Comments
No comments yet.